glp-1-based therapy GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Discovery of GLP-1–Based Drugs for

It has also been suggested that hepatic hypoinsulinemia may reduce insulin-like growth factor 1 (IGF-1) levels, which may contribute to IR as well by increasing growth hormone and IGF binding globulins (29)

People may be at higher risk for a B12 deficiency if they: Are age 50 and older: Several factors contribute to B12 deficiency in people over 50

Apply ice to the treated area to minimize swelling if any

To bridge these gaps, priorities for future work must include: (i) longitudinal, subtype-stratified multi-omics studies with repeated sampling to define temporal trajectories linking microbial functions to symptom flares